Home › Compare › KYSEY vs ABBV
KYSEY yields 2.90% · ABBV yields 3.06%● Live data
📍 KYSEY pulled ahead of the other in Year 6
Combined, KYSEY + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KYSEY + ABBV for your $10,000?
Kyushu Electric Power Company, Incorporated engages in the power generation, transmission, distribution, and sales in Japan and internationally. The company operates through Domestic Electric Power, Other Energy Service, ICT Service, and Other segments. It generates electricity from nuclear, thermal, hydroelectric, geothermal, internal combustion, wind, solar, poultry dung fuel, and biomass power energy sources. The company also receipts, stores, vaporizes, delivers, and sells LNG; purchases, operates, charters, and rents LNG carriers; manufactures and sells electric machinery, specialist equipment, concrete poles, HV and LV insulators, and other products; constructs, maintains, and repairs power generation facilities; buys, leases, manages, cleans, and maintains real estate properties; acquires and owns securities; recycles used confidential documents; and offers geothermal technical and air cargo transportation services, as well as housing and building reviews, assessments and guarantees. In addition, it installs, maintains, and manages electrical measurement equipment; and manufactures, installs, and maintains steel structures. Further, the company offers telecommunication devices, and fiber-optic cable and broadband services; elderly nursing home management and nursing, temporary staffing, and job-placement services; information systems; and computer software. Additionally, it is involved in the heat supply activities; environmental preservation work; consultation, planning, investigation, measurement, design, drafting, and care of civil engineering/construction projects; clerical work acceptance on trust and consulting business; data center business; investment activities; Internet website planning, development, and management; planning and operation of e-sports; management of golf courses; subtitle production for broadcasting; and ownership of mining interests and assets. The company was incorporated in 1951 and is headquartered in Fukuoka City, Japan.
Full KYSEY Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.